8 employees
Vaxdyn is a developer of multi-valent vaccines for preventing antibiotics-resistant infections.
2011
$7.3M
from 2 investors over 2 rounds
VAXDYN SL raised $892K on July 7, 2020
Investors: CARB-X
VAXDYN SL raised $7.3M on June 1, 2019